Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001888343 | SCV002143005 | uncertain significance | not provided | 2022-09-07 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 1377122). This variant has not been reported in the literature in individuals affected with POLR3A-related conditions. This variant is present in population databases (rs757718124, gnomAD 0.0009%). This sequence change replaces glycine, which is neutral and non-polar, with aspartic acid, which is acidic and polar, at codon 621 of the POLR3A protein (p.Gly621Asp). |
Neurometabolic Diseases Laboratory, |
RCV003388058 | SCV003920808 | likely pathogenic | POLR3A-related disorder | 2023-04-27 | criteria provided, single submitter | research |